EZH2 and embryonal rhabdomyosarcoma: The subtype analysis showed the sensitivity and specificity of EZH2 protein in ERMS were 89.47% and 100%, respectively, which illustrated that EZH2 expression is highly sensitive and specific to ERMS and it can be utilized as a reliable marker for differentiating ERMS from rhabdomyoma.